Meichun Hu

1.9k total citations
51 papers, 1.4k citations indexed

About

Meichun Hu is a scholar working on Molecular Biology, Organic Chemistry and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Meichun Hu has authored 51 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 7 papers in Organic Chemistry and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Meichun Hu's work include Histone Deacetylase Inhibitors Research (5 papers), Epigenetics and DNA Methylation (5 papers) and Renal and related cancers (5 papers). Meichun Hu is often cited by papers focused on Histone Deacetylase Inhibitors Research (5 papers), Epigenetics and DNA Methylation (5 papers) and Renal and related cancers (5 papers). Meichun Hu collaborates with scholars based in China, United States and Canada. Meichun Hu's co-authors include Norman D. Rosenblum, Rong Mo, Chi-chung Hui, Mingyao Liu, Dajun Liu, Jing Zheng, Zhengfang Yi, Qun Wan, Zhengsheng Zhang and Pao‐Tien Chuang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Molecular and Cellular Biology.

In The Last Decade

Meichun Hu

46 papers receiving 1.4k citations

Peers

Meichun Hu

ONCOL

GENET

Chunli Wei China

Longying Jiang China

Ling Shuai China

Wan‐Chun Li Taiwan

Shuping Yang China

Zhijie Liu United States

Berrin Tunca Türkiye

Yen‐Ni Teng Taiwan

Ünal Egelí Türkiye

Chunli Wei China

Meichun Hu

790 ×0.9

154 ×0.8

273 ×1.5

ONCOL

188 ×1.1

GENET

222 ×1.6

Citations per year, relative to Meichun Hu Meichun Hu (= 1×) peers Chunli Wei

Countries citing papers authored by Meichun Hu

Since Specialization

Citations

This map shows the geographic impact of Meichun Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meichun Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meichun Hu more than expected).

Fields of papers citing papers by Meichun Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meichun Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meichun Hu. The network helps show where Meichun Hu may publish in the future.

Co-authorship network of co-authors of Meichun Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Meichun Hu. A scholar is included among the top collaborators of Meichun Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meichun Hu. Meichun Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Hua, Meichun Hu, Ni Zhu, et al.. (2025). The protective effect of naringenin on ulcerative colitis in mice through increasing Nrf2 pathway activity. Acta Biochimica et Biophysica Sinica. 57(7). 1068–1080. 2 indexed citations

Dai, Mei, Shimin Chen, Yuanjing Wang, et al.. (2025). F-box proteins at the crossroads of ubiquitination and tumor immunity: regulatory networks and immunotherapy strategies. Frontiers in Immunology. 16. 1596344–1596344. 2 indexed citations

Cheng, Yan, et al.. (2025). Hydroxamic acid hybrids as histone deacetylase inhibitors for cancer therapy: an update (2022 to date). Bioorganic Chemistry. 163. 108700–108700. 3 indexed citations

Lu, Feifei, Qing Wu, Ni Zhu, et al.. (2024). Zeaxanthin impairs angiogenesis and tumor growth of glioblastoma: An in vitro and in vivo study. Archives of Biochemistry and Biophysics. 754. 109957–109957. 2 indexed citations

Zhao, Yahui, Zhangsheng Zhu, Meichun Hu, et al.. (2024). Genomic selection and genetic architecture of agronomic traits during modern flowering Chinese cabbage breeding. Horticulture Research. 12(2). uhae299–uhae299. 1 indexed citations

Hu, Meichun, et al.. (2024). Effects of self-management interventions based on the COM-B model on peri-implant condition in older adults with periodontitis: a randomized controlled trial. BMC Oral Health. 24(1). 1267–1267.

Hu, Meichun, et al.. (2024). Study on the application of quality control circle activity in postoperative nursing of elderly dental implants. Medicine. 103(2). e36894–e36894. 1 indexed citations

Fu, Yixiao, et al.. (2024). Antitumor properties of griseofulvin and its toxicity. Frontiers in Pharmacology. 15. 1459539–1459539. 5 indexed citations

Liu, Yifei, et al.. (2024). Role and regulation of FOXO3a: new insights into breast cancer therapy. Frontiers in Pharmacology. 15. 1346745–1346745. 5 indexed citations

10.

Yang, Tiantian, et al.. (2024). Bladder cancer immune-related markers: diagnosis, surveillance, and prognosis. Frontiers in Immunology. 15. 1481296–1481296. 4 indexed citations

11.

Hu, Meichun, et al.. (2023). First or Second Doses First? Vaccine Allocation Under Limited Supply. SSRN Electronic Journal. 2 indexed citations

12.

Li, Lin, Qing Wu, Feifei Lu, et al.. (2023). Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers. Frontiers in Oncology. 13. 66 indexed citations

13.

Wang, Yujing, Shuping Wang, Qingqing Wang, et al.. (2023). Identification of a luminescent platinum(II) complex with BODIPY derivative as novel photodynamic therapy agent for triple negative breast cancer cells. Journal of Inorganic Biochemistry. 242. 112160–112160. 5 indexed citations

14.

Li, Yan, Yen‐An Chen, Pei Liu, et al.. (2022). ALDH1: A potential therapeutic target for cancer stem cells in solid tumors. Frontiers in Oncology. 12. 1026278–1026278. 66 indexed citations

15.

Yan, Hongzhu, Yanling Sun, Meichun Hu, et al.. (2020). PELP1 Suppression Inhibits Gastric Cancer Through Downregulation of c-Src-PI3K-ERK Pathway. Frontiers in Oncology. 9. 1423–1423. 14 indexed citations

16.

Shen, Jia, Tao Zhang, Ni Zhu, et al.. (2018). Lycorine inhibits glioblastoma multiforme growth through EGFR suppression. Journal of Experimental & Clinical Cancer Research. 37(1). 157–157. 46 indexed citations

17.

Shen, Jia, Tao Zhang, Ni Zhu, et al.. (2018). Suppression of Non-Small Cell Lung Cancer Growth and Metastasis by a Novel Small Molecular Activator of RECK. Cellular Physiology and Biochemistry. 45(5). 1807–1817. 24 indexed citations

18.

He, Yundong, Shihong Peng, Jinhua Wang, et al.. (2016). Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer. Nature Communications. 7(1). 13122–13122. 79 indexed citations

19.

Mill, Pleasantine, Rong Mo, Meichun Hu, et al.. (2005). Shh Controls Epithelial Proliferation via Independent Pathways that Converge on N-Myc. Developmental Cell. 9(2). 293–303. 93 indexed citations

20.

Hu, Meichun, et al.. (2004). p38MAPK Acts in the BMP7-dependent Stimulatory Pathway during Epithelial Cell Morphogenesis and Is Regulated by Smad1. Journal of Biological Chemistry. 279(13). 12051–12059. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact